Logo image of CWAN

CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN - New York Stock Exchange, Inc. - US1851231068 - Common Stock - Currency: USD

31.26  +1.32 (+4.41%)

After market: 32 +0.74 (+2.37%)

Fundamental Rating

4

CWAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. CWAN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CWAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CWAN had positive earnings in the past year.
In the past year CWAN had a positive cash flow from operations.
CWAN had negative earnings in each of the past 5 years.
In multiple years CWAN reported negative operating cash flow during the last 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

The Return On Assets of CWAN (0.11%) is better than 60.87% of its industry peers.
CWAN's Return On Equity of 0.16% is fine compared to the rest of the industry. CWAN outperforms 62.32% of its industry peers.
CWAN has a better Return On Invested Capital (2.02%) than 67.03% of its industry peers.
Industry RankSector Rank
ROA 0.11%
ROE 0.16%
ROIC 2.02%
ROA(3y)-2.64%
ROA(5y)-6.82%
ROE(3y)-4.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 0.16%, CWAN is in the better half of the industry, outperforming 61.59% of the companies in the same industry.
CWAN has a Operating Margin of 3.21%. This is in the better half of the industry: CWAN outperforms 67.39% of its industry peers.
CWAN's Gross Margin of 72.25% is in line compared to the rest of the industry. CWAN outperforms 59.42% of its industry peers.
CWAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.21%
PM (TTM) 0.16%
GM 72.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.33%
GM growth 5YN/A
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CWAN is destroying value.
There is no outstanding debt for CWAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 21.30 indicates that CWAN is not in any danger for bankruptcy at the moment.
CWAN's Altman-Z score of 21.30 is amongst the best of the industry. CWAN outperforms 93.12% of its industry peers.
CWAN has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.38, CWAN is doing good in the industry, outperforming 76.81% of the companies in the same industry.
A Debt/Equity ratio of 0.11 indicates that CWAN is not too dependend on debt financing.
CWAN's Debt to Equity ratio of 0.11 is in line compared to the rest of the industry. CWAN outperforms 50.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.38
Altman-Z 21.3
ROIC/WACC0.14
WACC14.06%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 4.66 indicates that CWAN has no problem at all paying its short term obligations.
CWAN's Current ratio of 4.66 is amongst the best of the industry. CWAN outperforms 86.23% of its industry peers.
A Quick Ratio of 4.66 indicates that CWAN has no problem at all paying its short term obligations.
CWAN has a Quick ratio of 4.66. This is amongst the best in the industry. CWAN outperforms 86.23% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 4.66
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.35% over the past year.
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.72%

3.2 Future

Based on estimates for the next years, CWAN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.92% on average per year.
CWAN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.99% yearly.
EPS Next Y19.91%
EPS Next 2Y22.3%
EPS Next 3Y24.92%
EPS Next 5YN/A
Revenue Next Year19.67%
Revenue Next 2Y19.57%
Revenue Next 3Y18.99%
Revenue Next 5YN/A

3.3 Evolution

CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

CWAN is valuated quite expensively with a Price/Earnings ratio of 69.47.
CWAN's Price/Earnings ratio is in line with the industry average.
CWAN is valuated expensively when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 57.93, CWAN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CWAN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CWAN to the average of the S&P500 Index (22.68), we can say CWAN is valued expensively.
Industry RankSector Rank
PE 69.47
Fwd PE 57.93
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CWAN is on the same level as its industry peers.
CWAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 63.87
EV/EBITDA 284.99
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CWAN's earnings are expected to grow with 24.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.49
PEG (5Y)N/A
EPS Next 2Y22.3%
EPS Next 3Y24.92%

0

5. Dividend

5.1 Amount

No dividends for CWAN!.
Industry RankSector Rank
Dividend Yield N/A

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (2/21/2025, 8:11:27 PM)

After market: 32 +0.74 (+2.37%)

31.26

+1.32 (+4.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)N/A N/A
Inst Owners107.84%
Inst Owner Change14.06%
Ins Owners0.56%
Ins Owner Change24.84%
Market Cap7.77B
Analysts83.75
Price Target34.34 (9.85%)
Short Float %4.33%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.58%
Min EPS beat(2)-0.14%
Max EPS beat(2)7.3%
EPS beat(4)3
Avg EPS beat(4)9.32%
Min EPS beat(4)-0.14%
Max EPS beat(4)21.17%
EPS beat(8)7
Avg EPS beat(8)11.94%
EPS beat(12)10
Avg EPS beat(12)10.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)0.16%
Revenue beat(8)5
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.02%
PT rev (3m)27.31%
EPS NQ rev (1m)-1.19%
EPS NQ rev (3m)-1.98%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 69.47
Fwd PE 57.93
P/S 18.3
P/FCF 63.87
P/OCF 60.87
P/B 19.26
P/tB 26.33
EV/EBITDA 284.99
EPS(TTM)0.45
EY1.44%
EPS(NY)0.54
Fwd EY1.73%
FCF(TTM)0.49
FCFY1.57%
OCF(TTM)0.51
OCFY1.64%
SpS1.71
BVpS1.62
TBVpS1.19
PEG (NY)3.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.16%
ROCE 2.56%
ROIC 2.02%
ROICexc 4.77%
ROICexgc 9.18%
OM 3.21%
PM (TTM) 0.16%
GM 72.25%
FCFM 28.66%
ROA(3y)-2.64%
ROA(5y)-6.82%
ROE(3y)-4.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.33%
GM growth 5YN/A
F-Score7
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.38
Debt/EBITDA 1.76
Cap/Depr 53.02%
Cap/Sales 1.41%
Interest Coverage 3.83
Cash Conversion 511.98%
Profit Quality 18314.9%
Current Ratio 4.66
Quick Ratio 4.66
Altman-Z 21.3
F-Score7
WACC14.06%
ROIC/WACC0.14
Cap/Depr(3y)117.25%
Cap/Depr(5y)137.28%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y19.91%
EPS Next 2Y22.3%
EPS Next 3Y24.92%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.72%
Revenue Next Year19.67%
Revenue Next 2Y19.57%
Revenue Next 3Y18.99%
Revenue Next 5YN/A
EBIT growth 1Y188.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.84%
EBIT Next 3Y31.13%
EBIT Next 5Y29.02%
FCF growth 1Y171.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.14%
OCF growth 3YN/A
OCF growth 5YN/A